KWALITY PHARMACEUTICALS
Back to Balance Sheet
|
KWALITY PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹170 Cr | ₹152 Cr | ₹126 Cr | ₹139 Cr | ₹78 Cr |
What is the latest Total Current Liabilities ratio of KWALITY PHARMACEUTICALS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹170 Cr |
| Mar2024 | ₹152 Cr |
| Mar2023 | ₹126 Cr |
| Mar2022 | ₹139 Cr |
| Mar2021 | ₹78 Cr |
How is Total Current Liabilities of KWALITY PHARMACEUTICALS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹170 Cr | 11.63 | |
| Mar2024 | ₹152 Cr | 20.57 | |
| Mar2023 | ₹126 Cr | -9.71 | |
| Mar2022 | ₹139 Cr | 78.16 | |
| Mar2021 | ₹78 Cr | - | |
Compare Total Current Liabilities of peers of KWALITY PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KWALITY PHARMACEUTICALS | ₹2,874.8 Cr | 4.8% | 17.8% | 127.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹469,382.0 Cr | 0.8% | 7.3% | 15.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,375.0 Cr | 1.9% | 8.2% | 6.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,308.0 Cr | 0.6% | 12.6% | 43.9% | Stock Analytics | |
| CIPLA | ₹116,447.0 Cr | 0.2% | 6.3% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,106.0 Cr | -1.8% | -3.5% | -3.4% | Stock Analytics | |
KWALITY PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KWALITY PHARMACEUTICALS | 4.8% |
17.8% |
127.4% |
| SENSEX | 0.1% |
0.7% |
-6.6% |
You may also like the below Video Courses